Common side effects and treatments that may occur while taking Apremilast (Otelor)

Apremilast is an oral small molecule phosphodiesterase 4 (PDE4) inhibitor, mainly used to treat moderate to severe plaque psoriasis and psoriatic arthritis (PsA). It regulates inflammatory mediators and reduces the expression of pro-inflammatory cytokines (such as TNF-α, IL-17, IL-23), thereby alleviating skin lesions and joint inflammation. However, some patients may experience common side effects while taking them, and understanding these side effects and how to deal with them is important to ensure the safety and tolerability of the treatment.

First of all, the most common side effects are gastrointestinal reactions, including diarrhea, nausea, abdominal pain and indigestion. This kind of discomfort is usually more obvious a few weeks before taking the medicine. Most patients' symptoms can be relieved by themselves after continuing to take the medicine for 2 to 4 weeks. In order to reduce gastrointestinal discomfort, patients are advised to take the medication with food, avoid taking too many tablets at once on an empty stomach, and ensure adequate fluid intake. If the symptoms are severe, you can consult your doctor to adjust the dose, or use mild antidiarrheals or anti-nausea drugs under your doctor's guidance to relieve symptoms. In terms of daily diet, you can appropriately choose foods that are easy to digest, low in fat, and less irritating, such as rice soup, noodles, steamed vegetables, etc., to help reduce the burden on the gastrointestinal tract.

Secondly, apremilast may cause side effects related to the central nervous system, mainly manifesting as headache, insomnia, dizziness or mild mood swings. This is related to the drug's mild interference with neurotransmitter balance. Mild headaches or dizziness can be relieved by getting enough sleep, regular sleep schedules, moderate rest, and maintaining good fluid intake. If persistent insomnia or abnormal mood occurs, timely feedback should be provided to the doctor. If necessary, the medication plan can be adjusted or measures such as psychological support and behavioral intervention should be taken. Some patients may experience anxiety or mild depression in the early stages of medication, so they should pay close attention to their mental state during treatment and seek medical attention promptly if any abnormalities are found.

Third, apremilast may cause weight loss or changes in appetite in a small number of patients. Weight loss is usually mild to moderate, but in patients who are frail or at risk for malnutrition, weight and nutritional status should be monitored regularly. The effects of weight loss can be reduced by increasing the intake of highly nutritious, easily digestible meals, increasing protein and complex carbohydrates in moderation, or using nutritional supplements under the guidance of a doctor. If weight loss is significant or accompanied by weakness or fatigue, you should consult your doctor promptly and adjust the dose or suspend medication if necessary.

In addition, apremilast may cause a rash or mild allergic reaction manifesting as itching, erythema, or mild rash. Most rashes are mild and can be controlled with topical care or anti-allergy medications. Patients should stop taking the drug immediately and seek medical advice if they develop allergic symptoms such as severe rash, general itching, difficulty breathing or edema. Although apremilast is not a traditional immunosuppressant, some patients may still experience mild immune-related reactions, such as upper respiratory tract infections. They should maintain good personal hygiene and seek medical treatment in a timely manner.

In general, apremilast has shown good efficacy in the treatment of psoriasis and psoriatic arthritis, but gastrointestinal discomfort, headache/insomnia, weight changes and rash are more common side effects during use. Most side effects are mild to moderate and can be alleviated by taking the medicine with meals, regular work and rest, reasonable diet, psychological adjustment and local care. Patients should follow up regularly under the guidance of a doctor to monitor weight, mental status and skin reactions. If symptoms persist or worsen, they should seek medical treatment in time and adjust the dosage or discontinue medication if necessary. Through scientific management of side effects, most patients can safely and effectively complete apremilast treatment, significantly improving skin and joint symptoms and improving quality of life.

Reference materials:https://www.drugs.com/